drugset / Trial / NCT00633932
Reflux Esophagitis Phase III Study (Initial Treatment)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to evaluate the efficacy of esomeprazole 20 mg once daily and 40 mg once daily for 8 weeks on healing of Reflux Esophagitis in patients with reflux esophagitis in comparison with omeprazole 20 mg once daily by assessment of presence/absence of Reflux Esophagitis at Week 8 according to the Los Angeles classification .
Timeline
- Start
- 2007-12
- Primary completion
- —
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | Oral |
| Subject | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |